Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer

  • Khushbukhat Khan
  • , Cristina Quispe
  • , Zeeshan Javed
  • , Muhammad Javed Iqbal
  • , Haleema Sadia
  • , Shahid Raza
  • , Asma Irshad
  • , Bahare Salehi
  • , Željko Reiner
  • , Javad Sharifi-Rad

Research output: Contribution to journalReview articlepeer-review

80 Scopus citations

Abstract

Bladder cancer (BC) is a leading cause of death among urothelial malignancies that more commonly affect male population. Poor prognosis and resistance to chemotherapy are the two most important characteristics of this disease. PI3K/Akt/mTOR signaling pathway has been considered pivotal in the regulation of proliferation, migration, invasiveness, and metastasis. Deregulation of PI3K/Akt/mTOR signaling has been found in 40% of bladder cancers. Several microRNAs (miRNAs) have been reported to interact with the PI3K/Akt/mTOR signaling pathway with a different possible role in proliferation and apoptosis in bladder cancer. Thus, miRNAs can be used as potential biomarkers for BC. Natural compounds have been in the spotlight for the past decade due to their effective anti-proliferative capabilities. However, little is known of its possible effects in bladder cancer. The aim of this review is to discuss the interplay between PI3K/Akt/mTOR, miRNAs, and natural compounds and emphasize the importance of miRNAs as biomarkers and resveratrol, curcumin and paclitaxel as a possible therapeutic approach against bladder cancer.

Original languageEnglish
Article number560
JournalCancer Cell International
Volume20
Issue number1
DOIs
StatePublished - Dec 2020
Externally publishedYes

Keywords

  • Biomarkers
  • Drug resistance
  • Natural therapeutic
  • mTOR
  • miRNAs

Fingerprint

Dive into the research topics of 'Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer'. Together they form a unique fingerprint.

Cite this